awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q37142504-36AFCAA0-41F4-49E6-B8BF-2E3758F280ED
Q37142504-36AFCAA0-41F4-49E6-B8BF-2E3758F280ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37142504-36AFCAA0-41F4-49E6-B8BF-2E3758F280ED
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
P2860
Q37142504-36AFCAA0-41F4-49E6-B8BF-2E3758F280ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37142504-36AFCAA0-41F4-49E6-B8BF-2E3758F280ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72885f04f80b072264a57e6b4190eccce627696f
P2860
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma.